期刊文献+

儿童肾移植46例报道 被引量:5

A clinical study of pediatric and adolescent renal transplantation: a report of 46 cases
原文传递
导出
摘要 目的探讨儿童肾移植的手术特点、术后并发症及免疫抑制治疗方案。方法回顾性研究1998年2月至2004年12月46例儿童肾移植患者的临床资料。观察受者及移植肾存活情况,受者生长发育情况及术后并发症。结果46例儿童肾移植后发生急性排斥反应10例,肾功能延迟恢复4例,尿漏1例,肝功能损害8例,肺部感染8例,全骨髓抑制3例,粒细胞减少2例,输尿管坏死1例,移植肾动脉狭窄1例。术后4周所有患者肾功能均恢复正常。术后1年人和移植肾存活率均为100%,3年人和移植肾存活率分别为100%和97.4%。结论肾移植是治疗儿童终末期肾病的有效手段。儿童肾移植术后急性排斥发生率高,免疫抑制治疗应根据不同个体的特点制定不同的方案。 Objective To investigate the technical features, postoperative complication and therapeutic regimen of immunosuppressant in pediatric and adolescent renal transplantation. Methods From February 1998 to December 2004, clinical data of 46 pediatric and adolescent patients who underwent renal transplantation were retrospectively analyzed to observe the patient and graft survival rate, growth and development of recipients and postoperative complication. Results Ten episodes of acute rejection (AR) were diagnosed in 46 cases. Four cases suffered delayed graft function (DGF), one urinary leakage and 8 drug-induced hepatic injury occurred. Eight cases suffered pulmonary infection, 3 cases suffered bone marrow depression and 2 granulocytopenia. One allograft artery stenosis and one ureteral necrosis occurred. Renal functions were returned to normal in all recipients 4 weeks after operation. The 1-year patient and graft survival rates were all 100%, and the 3-year patient and graft survival rates were 100% and 97.4% respectively. Conclusions Renal transplantation is an effective treatment for pediatric and adolescent patients with end-stage renal disease. In addition to its higher AR incidence than adult, pediatric renal transplantation has especial treatment in the operation process and therapeutic regimen of immunosuppressant.
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2005年第12期751-754,共4页 Chinese Journal of Organ Transplantation
关键词 肾移植 儿童 免疫抑制剂 kidney transplantation child Immunosuppressant
  • 相关文献

参考文献8

  • 1孙晓毅,王果.小儿肾移植临床应用进展[J].中华小儿外科杂志,2003,24(4):360-362. 被引量:3
  • 2Smith JM,Nemeth TL,McDonald RA.Current immunosuppressive agents in pediatric renal transplantation:efficacy,sideeffects and utilization.Pectiatr Transplant,2004,8:445-453.
  • 3Duzova A,Buyan N,Bakkaloglu M,et al.Triple immunosuppression with or without basiliximab in pediatric renal transplantation:acute rejection rates at one year.Transplant Proc,2003,35:2878-2880.
  • 4Willetts IE,Trompeter RS.Experience with cyclosporine in pediatric renal transplantation.Transplant Proc,2004,36(Suppl):211-215.
  • 5Neu AM,Ho PL,Fine RN,et al.Tacrolimus vs.cyclosporine A as primary immunosuppression in pediatric renal transplantation:a NAPRTCS study.Pediatr Transplant,2003,7:217-222.
  • 6Dharnidharka VR,Sullivan EK,Stablein DM,et al.Risk factors for posttransplant lymphoproliferative disorder in pediatric kidney transplantation:a report of the North American Pediatric Renal Transplant Cooperative Study.Transplantation,2001,71:1065-1068.
  • 7Hasegawa A,Motoyama O,Shishido S,et al.A prospective trial of steroid withdrawal after renal transplantation in children:results obtained 1990 and 2002.Transplant Proc,2004,36(Suppl):216-219.
  • 8Jensen S,Jackson EC,Riley L,et al.Tacrolimus-based immunosuppression with steroid withdrawal in pediatric kidney transplantation-4-year experience at a moderate-volume center.Pediatr Transplant,2003,7:119-124.

二级参考文献25

  • 1Benfield MR, McDonald R, Sullivan EK,et al. The 1997 annual renal transplantation in children report of the north American pediatric renal transplant cooperative study(NAPRTCS). Pediatr Transplant, 1999,3:152-167.
  • 2Davis ID, Bunchman TE, Grimm PC, et al. Pediatric renal transplantation: Indications and special considerations. A position paper from the Pediatric Committee of the American Society of Transplant Physicians.Pediatr Transplant, 1998,2:117-129.
  • 3Tejani A, Sullivan EK. Dos ix-antigen-matched cadaver donor kidneys provide better graft survival to children compared with one-haploidentical living-related donor transplants? A report of the North American Pediatric Renal Transplant Cooperative Study.Pediatr Transplant, 2000,4:140-145.
  • 4Ishitani M, Isaacs R, Norwood V, et al.Predictors of graft survival in pediatric liv-ing-related kidney transplant recipients.Transplantation, 2000,70 : 288-292.
  • 5Millan MT, Sarwal MM, Lemley KV, et al. A 100% 2 year graft survival can be attained in high-risk 15 kg or smaller infant recipients of kidney allografts. Arch Surg,2000,135 : 1063-1068.
  • 6Vats AN, Donaldson L, Fine RN, et al.Pretransplant dialysis status and outcome of renal transplantation in North American children: A North American Pediatric Renal Transplant Cooperative Study. Transplantation, 2000,69:1414-1419.
  • 7Seikaly M, Ho PL, Emmett L, et al. The 12th annual report of the north American pediatric renal transplant cooperative study:Renal transplantation from 1987 through 1998. Pediatr Transplant, 2001, 5: 215:231.
  • 8Tejani A, Stablein DM, Donaldson L, et al. Steady improvement in short-term graft survival of pediatric renal transplants: The NAPRTCS experience. Clin Transpl, 1999.95-110.
  • 9Lashley DB, Barry JM,Demattos AM, et al. Kidney transplantation in children: A single center experience. J Urol, 1999,161:1920-1925.
  • 10Shapiro R, Nalesnik M, McCauley J, et al. Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation, 1999, 68:1851-1854.

共引文献2

同被引文献58

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部